title: Overexpression and Purification of C-terminal Fragment of the Passenger Domain of Hap Protein from Nontypeable Haemophilus influenzae in a Highly Optimized Escherichia coli Expression System.
abstract: BACKGROUND
  Nontypeable Haemophilus influenzae (NTHi) is a common cause of respiratory tract disease and initiates infection by colonization in nasopharynx. The Haemophilus influenzae (H. influenzae) Hap adhesin is an auto transporter protein that promotes initial interaction with human epithelial cells. Hap protein contains a 110 kDa internal passenger domain called "HapS" and a 45 kDa C-terminal translocator domain called "Hapβ". Hap adhesive activity has been recently reported to be connected to its Cell Binding Domain (CBD) which resides within the 311 C-terminal residues of the internal passenger domain of the protein. Furthermore, immunization with this CBD protein has been shown to prevent bacterial nasopharynx colonization in animal models.
  
  
  METHODS
  To provide enough amounts of pure HapS protein for vaccine studies, we sought to develop a highly optimized system to overexpress and purify the protein in large quantities. To this end, pET24a-cbd plasmid harboring cbd sequence from NTHi ATCC49766 was constructed and its expression was optimized by testing various expression parameters such as growth media, induction temperature, IPTG inducer concentration, induction stage and duration. SDS-PAGE and Western-blotting were used for protein analysis and confirmation and eventually the expressed protein was easily purified via immobilized metal affinity chromatography (IMAC) using Ni-NTA columns.
  
  
  RESULTS
  The highest expression level of target protein was achieved when CBD expressing E. coli BL21 (DE3) cells were grown at 37°C in 2xTY medium with 1.0 mM IPTG at mid-log phase (OD600 nm equal to 0.6) for 5 hrs. Amino acid sequence alignment of expressed CBD protein with 3 previously published CBD amino acid sequences were more than %97 identical and antigenicity plot analysis further revealed 9 antigenic domains which appeared to be well conserved among different analyzed CBD sequences.
  
  
  CONCLUSIONS
  Due to the presence of high similarity among CBD from NTHi ATCC49766 and other NTHi strains, CBD protein expressed here sounds to be theoretically ideal as a universal candidate for being used in vaccine studies against NTHi strains of various geographical areas. Further investigations to corroborate the potency of this protein as a vaccine candidate are under process.
authors.affiliation: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
authors.forename: Akram
authors.initials: A
authors.lastname: Tabatabaee
authors.forename: Seyed Davar
authors.initials: SD
authors.lastname: Siadat
authors.forename: Seyed Fazllolah
authors.initials: SF
authors.lastname: Moosavi
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Aghasadeghi
authors.forename: Arash
authors.initials: A
authors.lastname: Memarnejadian
authors.forename: Mohammad Hassan
authors.initials: MH
authors.lastname: Pouriayevali
authors.forename: Neda
authors.initials: N
authors.lastname: Yavari
keywords: Densitometry; Nontypeable Haemophilus influenzae; Optimization
references.citation: Pediatr Infect Dis J. 2009 Jan;28(1):43-8
references.pmid: 19057458
references.citation: J Infect Dis. 1987 Nov;156(5):723-31
references.pmid: 2443581
references.citation: Mol Microbiol. 1997 Nov;26(3):505-18
references.pmid: 9402021
references.citation: Int J Pediatr Otorhinolaryngol. 1999 Oct 5;49 Suppl 1:S227-9
references.pmid: 10577810
references.citation: Cell Microbiol. 2003 Mar;5(3):175-86
references.pmid: 12614461
references.citation: Pediatr Infect Dis J. 1997 Oct;16(10):931-5
references.pmid: 9380466
references.citation: J Infect Dis. 2002 Oct 15;186(8):1115-21
references.pmid: 12355362
references.citation: Protein Sci. 2009 May;18(5):936-48
references.pmid: 19384993
references.citation: J Clin Microbiol. 2003 Sep;41(9):4408-10
references.pmid: 12958278
references.citation: Infect Immun. 2002 Sep;70(9):4902-7
references.pmid: 12183535
references.citation: Am Rev Respir Dis. 1992 Oct;146(4):1067-83
references.pmid: 1416398
references.citation: Rev Infect Dis. 1987 Jan-Feb;9(1):1-15
references.pmid: 3547567
references.citation: Infect Immun. 2004 Dec;72(12):6961-8
references.pmid: 15557618
references.citation: Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
references.pmid: 388439
references.citation: FEMS Microbiol Rev. 1999 Apr;23(2):99-129
references.pmid: 10234841
references.citation: Infect Immun. 2009 Nov;77(11):4704-13
references.pmid: 19687208
references.citation: Curr Infect Dis Rep. 2009 May;11(3):177-82
references.pmid: 19366559
references.citation: Mol Microbiol. 1994 Oct;14(2):217-33
references.pmid: 7830568
references.citation: FEBS Lett. 1990 Dec 10;276(1-2):172-4
references.pmid: 1702393
references.citation: Mol Cell. 1998 Dec;2(6):841-50
references.pmid: 9885571